<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39311212</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2036-7430</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Infectious disease reports</Title><ISOAbbreviation>Infect Dis Rep</ISOAbbreviation></Journal><ArticleTitle>Obesity Parameters as Predictor of Poor Outcomes in Hospitalized Patients with Confirmed Mild-to-Moderate COVID-19.</ArticleTitle><Pagination><StartPage>894</StartPage><EndPage>905</EndPage><MedlinePgn>894-905</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/idr16050071</ELocationID><Abstract><AbstractText>(1) Background: This study aims to assess visceral fat values, waist circumference (WC), body mass index (BMI), and body fat percentage for their ability to predict poor outcomes during COVID-19 patients' hospitalization; (2) Methods: This study was a prospective cohort of mild-moderate COVID-19 patients hospitalized at Dr. Cipto Mangunkusumo National General Hospital from December 2020 to March 2021. This study includes hospitalized patients over 18 diagnosed with COVID-19 using RT-PCR. Patients who do not have chest radiography, waist circumference, a bioimpedance analyzer (BIA) error, or are unable to stand or mobilize during the examination are excluded from this study. Cox regression was used for multivariate analysis; (3) Results: The study included two hundred sixty-one patients. The median visceral fat value was 10 (equivalent to 100 cm<sup>2</sup>), the WC was 93.4 cm, the BMI was 26.1 kg/m<sup>2</sup>, and the body fat percentage was 31.5%. Based on multivariate Cox regression, WC was statistically significant as an independent factor influencing poor outcomes in COVID-19 patients (RR 1.037 [95% CI 1.011-1.064]) along with COVID-19 degree of severity (RR 3.063 [95% CI 1.537-6.104]) and comorbidities (RR 2.123 [95% CI 1.017-4.435]); (4) Conclusions: Waist circumference can influence poor outcomes in confirmed COVID-19 patients during hospitalization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barus</LastName><ForeName>Nadya R V</ForeName><Initials>NRV</Initials><Identifier Source="ORCID">0009-0002-3730-7914</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahapary</LastName><ForeName>Dicky Levenus</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0002-4048-5159</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Unit, Dr. Cipto Mangunkusumo National General Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurniawan</LastName><ForeName>Farid</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinto</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Tropical Disease and Infection, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wafa</LastName><ForeName>Syahidatul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisnu</LastName><ForeName>Wismandari</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-2172-6703</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansjoer</LastName><ForeName>Arif</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8675-8063</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijaya</LastName><ForeName>Calysta Nadya</ForeName><Initials>CN</Initials><Identifier Source="ORCID">0009-0007-6854-3430</Identifier><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felix</LastName><ForeName>Immanuel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4903-8056</Identifier><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarigan</LastName><ForeName>Tri Juli Edi</ForeName><Initials>TJE</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harbuwono</LastName><ForeName>Dante Saksono</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-6006-2719</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soewondo</LastName><ForeName>Pradana</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NKB-763/UN2.RST/HKP.05.00/2020</GrantID><Agency>Universitas Indonesia Grant (PUTI KI 2 Q2</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Infect Dis Rep</MedlineTA><NlmUniqueID>101537203</NlmUniqueID><ISSNLinking>2036-7430</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19 severity</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">poor outcome</Keyword><Keyword MajorTopicYN="N">waist circumference</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the study’s design, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311212</ArticleId><ArticleId IdType="pmc">PMC11417886</ArticleId><ArticleId IdType="doi">10.3390/idr16050071</ArticleId><ArticleId IdType="pii">idr16050071</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cai Q., Chen F., Wang T., Luo F., Liu X., Wu Q., He Q., Wang Z., Liu Y., Liu L., et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43:1392–1398. doi: 10.2337/dc20-0576.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0576</ArticleId><ArticleId IdType="pubmed">32409502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreher M., Kersten A., Bickenbach J., Balfanz P., Hartmann B., Cornelissen C., Daher A., Stöhr R., Kleines M., Lemmen S.W., et al. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch. Ärzteblatt Int. 2020;117:271–278. doi: 10.3238/arztebl.2020.0271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2020.0271</ArticleId><ArticleId IdType="pmc">PMC7171478</ArticleId><ArticleId IdType="pubmed">32519944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalligeros M., Shehadeh F., Mylona E.K., Benitez G., Beckwith C.G., Chan P.A., Mylonakis E. Association of obesity with disease severity among patients with COVID-19. Obesity. 2020;28:1200–1204. doi: 10.1002/oby.22859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22859</ArticleId><ArticleId IdType="pmc">PMC7267224</ArticleId><ArticleId IdType="pubmed">32352637</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S., Southern W.N., Mantzoros C.S. Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType="pmc">PMC7228874</ArticleId><ArticleId IdType="pubmed">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahapary D.L., Soewondo P. Burden of metabolic diseases in Indonesia: An even more critical issue during COVID-19 pandemic. Med. J. Indones. 2020;29:347–349. doi: 10.13181/mji.ed.205208.</Citation><ArticleIdList><ArticleId IdType="doi">10.13181/mji.ed.205208</ArticleId></ArticleIdList></Reference><Reference><Citation>Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI . Hasil Utama RISKESDAS 2018. Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan; Jakarta, Indonesia: 2018.</Citation></Reference><Reference><Citation>Sachs J.D., Abdool Karim S., Aknin L., Allen J., Brosbøl K., Cuevas Barron G., Daszak P., Espinosa M.F., Gaspar V., Gaviria A., et al. Lancet COVID-19 commission statement on the occasion of the 75th session of the UN general assembly. Lancet. 2020;396:1102–1124. doi: 10.1016/S0140-6736(20)31927-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31927-9</ArticleId><ArticleId IdType="pmc">PMC7489891</ArticleId><ArticleId IdType="pubmed">32941825</ArticleId></ArticleIdList></Reference><Reference><Citation>Post A., Bakker S.J.L., Dullaart R.P.F. Obesity, adipokines and COVID-19. Eur. J. Clin. Investig. 2020;50:e13313. doi: 10.1111/eci.13313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13313</ArticleId><ArticleId IdType="pmc">PMC7323011</ArticleId><ArticleId IdType="pubmed">32531806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura T., Namkoong H. Susceptibility of the obese population to COVID-19. Int. J. Infect. Dis. 2020;101:380–381. doi: 10.1016/j.ijid.2020.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.015</ArticleId><ArticleId IdType="pmc">PMC7546690</ArticleId><ArticleId IdType="pubmed">33045426</ArticleId></ArticleIdList></Reference><Reference><Citation>Méry G., Epaulard O., Borel A.L., Toussaint B., Le Gouellec A. COVID-19: Underlying adipokine storm and angiotensin 1–7 umbrella. Front. Immunol. 2020;11:1714. doi: 10.3389/fimmu.2020.01714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01714</ArticleId><ArticleId IdType="pmc">PMC7385229</ArticleId><ArticleId IdType="pubmed">32793244</ArticleId></ArticleIdList></Reference><Reference><Citation>Földi M., Farkas N., Kiss S., Dembrovszky F., Szakács Z., Balaskó M., Erőss B., Hegyi P., Szentesi A. Visceral adiposity elevates the risk of critical condition in COVID-19: A systematic review and meta-analysis. Obesity. 2020;29:521–528. doi: 10.1002/oby.23096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23096</ArticleId><ArticleId IdType="pmc">PMC7753720</ArticleId><ArticleId IdType="pubmed">33263191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gammone M.A., D’Orazio N. Review: Obesity and COVID-19: A detrimental intersection. Front. Endocrinol. 2021;12:652639. doi: 10.3389/fendo.2021.652639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.652639</ArticleId><ArticleId IdType="pmc">PMC8121172</ArticleId><ArticleId IdType="pubmed">33995281</ArticleId></ArticleIdList></Reference><Reference><Citation>Adenote A., Dumic I., Madrid C., Barusya C., Nordstrom C.W., Rueda Prada L. NAFLD and Infection, a Nuanced Relationship. Can. J. Gastroenterol. Hepatol. 2021;2021:5556354. doi: 10.1155/2021/5556354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5556354</ArticleId><ArticleId IdType="pmc">PMC8087474</ArticleId><ArticleId IdType="pubmed">33977096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad A.S., Juber N.F., Al-Naseri H., Heumann C., Ali R., Oliver T. Association between Average Vitamin D Levels and COVID-19 Mortality in 19 European Countries—A Population-Based Study. Nutrients. 2023;15:4818. doi: 10.3390/nu15224818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15224818</ArticleId><ArticleId IdType="pmc">PMC10680994</ArticleId><ArticleId IdType="pubmed">38004213</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzohily B., AlMenhali A., Gariballa S., Munawar N., Yasin J., Shah I. Unraveling the complex interplay between obesity and vitamin D metabolism. Sci. Rep. 2024;14:7583. doi: 10.1038/s41598-024-58154-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-58154-z</ArticleId><ArticleId IdType="pmc">PMC10981658</ArticleId><ArticleId IdType="pubmed">38555277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H., Berg E., Cheng X., Shen W. How to best assess abdominal obesity. Curr. Opin. Clin. Nutr. Metab. Care. 2018;21:360–365. doi: 10.1097/MCO.0000000000000485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000485</ArticleId><ArticleId IdType="pmc">PMC6299450</ArticleId><ArticleId IdType="pubmed">29916924</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelnuovo G., De Cuevillas B., Navas-Carretero S., Alfredo Martínez J. Body fat mass assessment and obesity classification: A review of the available methods for adiposity estimation. Prog. Nutr. 2021;23:e2021014.</Citation></Reference><Reference><Citation>World Health Organization . Clinical Management of COVID-19: Interim Guidance 27 May 2020. World Health Organization; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Tanita Asia Pasific.  [(accessed on 13 August 2024)].  Available online:  https://tanita.asia/upload/manual/5/download/5914678439f19.pdf.</Citation></Reference><Reference><Citation>World Health Organization . Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. World Health Organization; Geneva, Switzerland: 2008.</Citation></Reference><Reference><Citation>National Clinical Effectiveness Committee HSE National Early Warning Score: National Clinical Guideline No.1. Nurs. Older People. 2018;30:12. doi: 10.7748/nop.30.2.12.s11.</Citation><ArticleIdList><ArticleId IdType="doi">10.7748/nop.30.2.12.s11</ArticleId></ArticleIdList></Reference><Reference><Citation>Riviello E.D., Buregeya E., Fowler R.A., Talmor D.S., Twagirumugabe T., Kiviri W. Diagnosing acute respiratory distress syndrome in resource limited settings: The Kigali modification of the Berlin definition. Curr. Opin. Crit. Care. 2017;23:18–23. doi: 10.1097/MCC.0000000000000372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000372</ArticleId><ArticleId IdType="pubmed">27875408</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakše B., Pinter S., Jakše B., Pajek M.B., Pajek J. Effects of an ad libitum consumed low-fat plant-based diet supplemented with plant-based meal replacements on body composition indices. Biomed Res. Int. 2017;2017:9626390. doi: 10.1155/2017/9626390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/9626390</ArticleId><ArticleId IdType="pmc">PMC5387822</ArticleId><ArticleId IdType="pubmed">28459071</ArticleId></ArticleIdList></Reference><Reference><Citation>TANITA . Body Composition Guide for InnerScan. TANITA Asia; Hong Kong, China: 2015.</Citation></Reference><Reference><Citation>Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome—A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006;23:469–480. doi: 10.1111/j.1464-5491.2006.01858.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2006.01858.x</ArticleId><ArticleId IdType="pubmed">16681555</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Western Pacific Region . The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia; Bundaberg, Australia: 2000.</Citation></Reference><Reference><Citation>Gallagher D., Heymsfield S.B., Heo M., Jebb S.A., Murgatroyd P.R., Sakamoto Y. Healthy percentage body fat ranges: An approach for developing guidelines based on body mass index. Am. J. Clin. Nutr. 2000;76:694–701. doi: 10.1093/ajcn/72.3.694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/72.3.694</ArticleId><ArticleId IdType="pubmed">10966886</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobellis G., Malavazos A.E., Ferreira T. COVID-19 rise in younger adults with obesity: Visceral adiposity can predict the risk. Obesity. 2020;28:1795. doi: 10.1002/oby.22951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22951</ArticleId><ArticleId IdType="pmc">PMC7361935</ArticleId><ArticleId IdType="pubmed">32619294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandarana H., Dane B., Mikheev A., Taffel M.T., Feng Y., Rusinek H. Visceral adipose tissue in patients with COVID-19: Risk stratification for severity. Abdom. Radiol. 2020;46:818–825. doi: 10.1007/s00261-020-02693-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00261-020-02693-2</ArticleId><ArticleId IdType="pmc">PMC7398639</ArticleId><ArticleId IdType="pubmed">32748252</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen A., Bressem K., Albrecht J., Thieß H.M., Vahldiek J., Hamm B., Makowski M.R., Niehues A., Niehues S.M., Adams L.C. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. 2020;110:154317. doi: 10.1016/j.metabol.2020.154317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154317</ArticleId><ArticleId IdType="pmc">PMC7358176</ArticleId><ArticleId IdType="pubmed">32673651</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavazos A.E., Secchi F., Basilico S., Capitanio G., Boveri S., Milani V., Dubini C., Schiaffino S., Morricone L., Foschini C., et al. Abdominal obesity phenotype is associated with COVID-19 chest X-ray severity score better than BMI-based obesity. Eat. Weight. Disord. 2021;27:345–359. doi: 10.1007/s40519-021-01173-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40519-021-01173-w</ArticleId><ArticleId IdType="pmc">PMC8020829</ArticleId><ArticleId IdType="pubmed">33821453</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamdari N.M., Rahimi F.S., Afaghi S., Zarghi A., Qaderi S., Tarki F.E., Ghafouri S.R., Besharat S. The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:1979–1986. doi: 10.1016/j.dsx.2020.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7550894</ArticleId><ArticleId IdType="pubmed">33080538</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalangot M., Sheichenko N., Gurianov V., Vlasenko V., Kurinna Y., Samson O., Tronko M. Relationship between hyperglycemia, waist circumference, and the course of COVID-19: Mortality risk assessment. Exp. Biol. Med. 2021;247:200–206. doi: 10.1177/15353702211054452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15353702211054452</ArticleId><ArticleId IdType="pmc">PMC8851533</ArticleId><ArticleId IdType="pubmed">34670418</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zelst C.M., Janssen M.L., Pouw N., Birnie E., Braunstahl J., Cabezas M.C. Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19. BMJ Open Respir. Res. 2020;7:e000792. doi: 10.1136/bmjresp-2020-000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000792</ArticleId><ArticleId IdType="pmc">PMC7745457</ArticleId><ArticleId IdType="pubmed">33328246</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen R.A.G., Sturrock S.L., Arneja J., Brooks J.D. Measures of adiposity and risk of testing positive for SARS-CoV-2 in the UK Biobank Study. J. Obes. 2021;2021:8837319. doi: 10.1155/2021/8837319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8837319</ArticleId><ArticleId IdType="pmc">PMC7841447</ArticleId><ArticleId IdType="pubmed">33542836</ArticleId></ArticleIdList></Reference><Reference><Citation>Freuer D., Linseisen J., Meisinger C. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study. Metabolism. 2021;118:154732. doi: 10.1016/j.metabol.2021.154732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154732</ArticleId><ArticleId IdType="pmc">PMC7900753</ArticleId><ArticleId IdType="pubmed">33631142</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornier M.A., Després J.P., Davis N., Grossniklaus D.A., Klein S., Lamarche B., Lopez-Jimenez F., Rao G., St-Onge M.P., Towfighi A., et al. Assessing adiposity: A scientific statement from the American Heart Association. Circulation. 2011;124:1996–2019. doi: 10.1161/CIR.0b013e318233bc6a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0b013e318233bc6a</ArticleId><ArticleId IdType="pubmed">21947291</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscogiuri G., Pugliese G., Barrea L., Colao A. Obesity: The “achilles heel” for COVID-19? Metabolism. 2020;108:154251. doi: 10.1016/j.metabol.2020.154251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154251</ArticleId><ArticleId IdType="pmc">PMC7184987</ArticleId><ArticleId IdType="pubmed">32353356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritter A., Kreis N.N., Louwen F., Yuan J. Obesity and COVID-19: Molecular mechanisms linking both pandemics. Int. J. Mol. Sci. 2020;21:5793. doi: 10.3390/ijms21165793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165793</ArticleId><ArticleId IdType="pmc">PMC7460849</ArticleId><ArticleId IdType="pubmed">32806722</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalakis K., Ilias I. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:469–471. doi: 10.1016/j.dsx.2020.04.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.033</ArticleId><ArticleId IdType="pmc">PMC7189186</ArticleId><ArticleId IdType="pubmed">32387864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gammone M.A., D’Orazio N. COVID-19 and obesity: Overlapping of two pandemics. Obes. Facts. 2021;14:579–585. doi: 10.1159/000518386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518386</ArticleId><ArticleId IdType="pmc">PMC8678214</ArticleId><ArticleId IdType="pubmed">34569546</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Lu Y., Huang Y.-M., Wang M., Ling W., Sui Y., Zhao H.-L. Obesity in patients with COVID-19: A systematic review and meta-analysis. Metabolism. 2020;113:154378. doi: 10.1016/j.metabol.2020.154378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154378</ArticleId><ArticleId IdType="pmc">PMC7521361</ArticleId><ArticleId IdType="pubmed">33002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang I.S., Kong K.A. Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea. PLoS ONE. 2021;16:e0253640. doi: 10.1371/journal.pone.0253640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253640</ArticleId><ArticleId IdType="pmc">PMC8219144</ArticleId><ArticleId IdType="pubmed">34157043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S.W.X., Young B.E., Leo Y.-S., Lye D.C. Association of higher body mass index with severe coronavirus disease 2019 (COVID-19) in younger patients. Clin. Infect. Dis. 2020;71:2300–2302. doi: 10.1093/cid/ciaa548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa548</ArticleId><ArticleId IdType="pmc">PMC7239262</ArticleId><ArticleId IdType="pubmed">32382755</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayanama K., Srichatrapimuk S., Thammavaranucupt K., Kirdlarp S., Suppadungsuk S., Wongsinin T., Nanthatanti N., Phusanti S., Pitidhammabhorn D., Sungkanuparph S. The association between body mass index and severity of coronavirus disease 2019 (COVID-19): A cohort study. PLoS ONE. 2021;16:e0247023. doi: 10.1371/journal.pone.0247023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247023</ArticleId><ArticleId IdType="pmc">PMC7886119</ArticleId><ArticleId IdType="pubmed">33592042</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O’Donnell L., Chernyak Y., Tobin K.A., Cerfolio R.J., Francois F., Horwitz L.I. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M., Pistillo A., Fernandez-bertolin S., Roel E., Aragon M., Freisling H., Prieto-alhambra D. Body mass index and risk of COVID-19 diagnosis, hospitalization, and death: A cohort study of 2.524.926 Catalans. J. Clin. Endocrinol. Metab. 2021;106:5030–5042. doi: 10.1210/clinem/dgab546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab546</ArticleId><ArticleId IdType="pmc">PMC8344917</ArticleId><ArticleId IdType="pubmed">34297116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjögren L., Stenberg E., Thuccani M., Martikainen J., Rylander C., Wallenius V., Olbers T., Kindblom J.M. Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study. PLoS ONE. 2021;16:e0257891. doi: 10.1371/journal.pone.0257891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257891</ArticleId><ArticleId IdType="pmc">PMC8513867</ArticleId><ArticleId IdType="pubmed">34644316</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates T., Razieh C., Zaccardi F., Davies M.J., Khunti K. Obesity and risk of COVID-19: Analysis of UK biobank. Prim. Care Diabetes. 2020;14:566–567. doi: 10.1016/j.pcd.2020.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2020.05.011</ArticleId><ArticleId IdType="pmc">PMC7254007</ArticleId><ArticleId IdType="pubmed">32493608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Ding L., Zou X., Shen Y., Hu D., Hu X., Li Z., Kamel I.R. Visceral adiposity and high intramuscular fat deposition independently predict critical illness in patients with SARS-CoV-2. Obesity. 2020;28:2040–2048. doi: 10.1002/oby.22971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22971</ArticleId><ArticleId IdType="pmc">PMC7405187</ArticleId><ArticleId IdType="pubmed">32677752</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Caruso D., Tuccinardi D., Risi R., Zerunian M., Polici M., Pucciarelli F., Tarallo M., Strigari L., Manfrini S., et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism. 2020;111:154319. doi: 10.1016/j.metabol.2020.154319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154319</ArticleId><ArticleId IdType="pmc">PMC7377788</ArticleId><ArticleId IdType="pubmed">32712222</ArticleId></ArticleIdList></Reference><Reference><Citation>Favre G., Legueult K., Pradier C., Raffaelli C., Ichai C., Iannelli A., Redheuil A., Lucidarme O., Esnault V. Visceral fat is associated to the severity of COVID-19. Metabolism. 2021;115:154440. doi: 10.1016/j.metabol.2020.154440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154440</ArticleId><ArticleId IdType="pmc">PMC7685947</ArticleId><ArticleId IdType="pubmed">33246009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R., Lim M.A., Huang I., Yonas E., Henrina J., Vania R., Lukito A.A., Nasution S.A., Alwi I., Siswanto B.B. Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. Clin. Nutr. ESPEN. 2021;43:163–168. doi: 10.1016/j.clnesp.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8032475</ArticleId><ArticleId IdType="pubmed">34024509</ArticleId></ArticleIdList></Reference><Reference><Citation>Blüher M. Metabolically healthy obesity. Endocr. Rev. 2020;41:405–420. doi: 10.1210/endrev/bnaa004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnaa004</ArticleId><ArticleId IdType="pmc">PMC7098708</ArticleId><ArticleId IdType="pubmed">32128581</ArticleId></ArticleIdList></Reference><Reference><Citation>Helvaci N., Eyupoglu N.D., Karabulut E., Yildiz B.O. Prevalence of obesity and its impact on outcome in patients with COVID-19: A systematic review and meta-analysis. Front. Endocrinol. 2021;12:598249. doi: 10.3389/fendo.2021.598249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.598249</ArticleId><ArticleId IdType="pmc">PMC7947815</ArticleId><ArticleId IdType="pubmed">33716962</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawadogo W., Tsegaye M., Gizaw A., Adera T. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: Systematic review and meta-analysis. BMJ Nutr. Prev. Health. 2022;5:10–18. doi: 10.1136/bmjnph-2021-000375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2021-000375</ArticleId><ArticleId IdType="pmc">PMC8783972</ArticleId><ArticleId IdType="pubmed">35814718</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R., Lim M.A., Yonas E., Vania R., Lukito A.A., Siswanto B.B., Meyer M. Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis. Diabetes Metab. 2021;47:101178. doi: 10.1016/j.diabet.2020.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7388778</ArticleId><ArticleId IdType="pubmed">32738402</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbuwono D.S., Handayani D.O.T.L., Wahyuningsih E.S., Supraptowati N., Ananda, Kurniawan F., Wafa S., Kristanti M., Pantoro N.I., Sinto R., et al. Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta’s COVID-19 epidemiological registry. Prim. Care Diabetes. 2022;16:65–68. doi: 10.1016/j.pcd.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8585608</ArticleId><ArticleId IdType="pubmed">34857490</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen C.J., Murphy K.E., Fernandez M.L. Impact of obesity and metabolic syndrome on immunity. Adv. Nutr. 2016;7:66–75. doi: 10.3945/an.115.010207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.115.010207</ArticleId><ArticleId IdType="pmc">PMC4717890</ArticleId><ArticleId IdType="pubmed">26773015</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal M., Kern P.A., Nikolajczyk B.S. The Immune System in Obesity: Developing Paradigms Amidst Inconvenient Truths. Curr. Diab. Rep. 2017;17:87. doi: 10.1007/s11892-017-0917-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-017-0917-9</ArticleId><ArticleId IdType="pmc">PMC6826336</ArticleId><ArticleId IdType="pubmed">28812211</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerriets V.A., MacIver N.J. Role of T cells in malnutrition and obesity. Front. Immunol. 2014;5:379. doi: 10.3389/fimmu.2014.00379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00379</ArticleId><ArticleId IdType="pmc">PMC4127479</ArticleId><ArticleId IdType="pubmed">25157251</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.M., Levings M.K. Immune Regulation in Obesity-Associated Adipose Inflammation. J. Immunol. 2013;191:527–532. doi: 10.4049/jimmunol.1301035.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301035</ArticleId><ArticleId IdType="pubmed">23825387</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebello C.J., Kirwan J.P., Greenway F.L. Obesity, the most common comorbidity in SARS-CoV-2: Is leptin the link? Int. J. Obes. 2020;44:1810–1817. doi: 10.1038/s41366-020-0640-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0640-5</ArticleId><ArticleId IdType="pmc">PMC7347260</ArticleId><ArticleId IdType="pubmed">32647360</ArticleId></ArticleIdList></Reference><Reference><Citation>Misumi I., Starmer J., Uchimura1 T., Beck M.A., Magnuson T., Whitmire J.K. Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection. Cell Rep. 2019;27:514–524. doi: 10.1016/j.celrep.2019.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.030</ArticleId><ArticleId IdType="pmc">PMC6652206</ArticleId><ArticleId IdType="pubmed">30970254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D., et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., Bécavin C., Berg M., Queen R., Litvinukova M., Talavera-López C., Maatz H., Reichart D., Sampaziotis F., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681–687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495–506. doi: 10.1161/01.CIR.82.2.495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.82.2.495</ArticleId><ArticleId IdType="pubmed">2372896</ArticleId></ArticleIdList></Reference><Reference><Citation>Trpkovic A., Resanovic I., Stanimirovic J., Radak D., Mousa S.A., Cenic-Milosevic D., Jevremovic D., Isenovic E.R. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit. Rev. Clin. Lab. Sci. 2015;52:70–85. doi: 10.3109/10408363.2014.992063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10408363.2014.992063</ArticleId><ArticleId IdType="pubmed">25537066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryoo S., Bhunia A., Chang F., Shoukas A., Berkowitz D.E., Romer L.H. OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis. 2011;214:279–287. doi: 10.1016/j.atherosclerosis.2010.10.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2010.10.044</ArticleId><ArticleId IdType="pmc">PMC3031764</ArticleId><ArticleId IdType="pubmed">21130456</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas A.M., Fathy S.K., Fawzy A.T., Salem A.S., Shawky M.S. The mutual effects of COVID-19 and obesity. Obes. Med. 2020;19:100250. doi: 10.1016/j.obmed.2020.100250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2020.100250</ArticleId><ArticleId IdType="pmc">PMC7202807</ArticleId><ArticleId IdType="pubmed">32382684</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudatsir M., Fajar J.K., Wulandari L., Soegiarto G., Ilmawan M., Purnamasari Y., Mahdi B.A., Jayanto G.D., Suhendra S., Setianingsih Y.A., et al. Predictors of COVID-19 severity: A systematic review and meta-analysis. F1000Research. 2021;9:1107. doi: 10.12688/f1000research.26186.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.26186.2</ArticleId><ArticleId IdType="pmc">PMC7607482</ArticleId><ArticleId IdType="pubmed">33163160</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutiérrez-Ocampo E., Villamizar-Peña R., Holguin-Rivera Y., Escalera-Antezana J.P., Alvarado-Arnez L.E., Bonilla-Aldana D.K., Franco-Paredes C., Henao-Martinez A.F., et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101623</ArticleId><ArticleId IdType="pmc">PMC7102608</ArticleId><ArticleId IdType="pubmed">32179124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>